Strong Balance Sheet Stocks

Results

3581

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

3581 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	RADA	US$9.87	-2.4%	5.0%	US$490.9m	US$14.00	85.0	83.7%	n/a	Capital Goods
	FFHL	US$8.30	0.7%	8.1%	US$27.1m	n/a	2.8	n/a	n/a	Materials
	PBIP	US$15.13	-0.7%	9.6%	US$117.7m	US$15.00	1.0	87.9%	1.9%	Banks
	BKFG	US$94.00	0%	n/a	US$54.8m	n/a	6.8	n/a	n/a	Diversified Financials
	GRVY	US$66.82	2.0%	7.7%	US$473.5m	n/a	9.6	n/a	n/a	Media
	TYBT	US$96.25	0%	n/a	US$105.2m	n/a	1.7	n/a	2.1%	Banks
	TARA	US$4.00	0.5%	34.2%	US$226.5m	US$26.57	1.2	50.5%	n/a	Pharmaceuticals & Biotech
	SGMT	US$6.86	2.7%	-21.1%	US$427.9m	US$26.20	4.1	16.2%	n/a	Pharmaceuticals & Biotech
	SOMC	US$32.00	1.6%	52.4%	US$148.9m	n/a	1.2	n/a	2.1%	Banks
	ORPB	US$11.18	0%	41.7%	US$80.1m	n/a	1.0	n/a	n/a	Banks
	BGIN	US$1.80	-10.9%	n/a	US$215.0m	n/a	3.0	n/a	n/a	Tech
	ATRC	US$28.13	-2.3%	-14.4%	US$1.4b	US$47.00	2.6	51.0%	n/a	Healthcare
	BRNS	US$0.72	8.6%	-22.1%	US$27.0m	US$5.50	0.4	n/a	n/a	Pharmaceuticals & Biotech
	OAKC	US$38.38	0.7%	26.7%	US$193.2m	n/a	1.3	n/a	1.2%	Banks
	VNDA	US$5.85	0.9%	21.4%	US$354.8m	US$14.13	1.6	62.4%	n/a	Pharmaceuticals & Biotech
	TRVI	US$18.00	4.6%	218.0%	US$2.5b	US$23.90	14.8	-6.5%	n/a	Pharmaceuticals & Biotech
	EBMT	US$23.42	2.2%	41.4%	US$186.0m	US$23.83	1.0	4.6%	2.5%	Banks
	CZWI	US$22.82	6.9%	67.2%	US$213.8m	US$24.00	1.2	20.3%	1.8%	Banks
	GHRS	US$25.34	13.9%	104.4%	US$1.7b	US$39.50	6.6	3.9%	n/a	Pharmaceuticals & Biotech
	FTFI	US$38.25	-1.2%	n/a	US$100.1m	n/a	1.2	n/a	0.7%	Banks
	SLN	US$10.00	44.3%	80.5%	US$432.7m	US$29.17	563.0	-26.5%	n/a	Pharmaceuticals & Biotech
	AUBN	US$26.53	4.4%	7.1%	US$88.8m	n/a	1.0	n/a	4.1%	Banks
	SBSI	US$35.13	4.5%	19.7%	US$1.0b	US$37.00	1.2	19.2%	4.1%	Banks
	NXDR	US$2.12	-3.6%	34.2%	US$827.6m	US$2.64	3.0	59.6%	n/a	Media

Page 1 of 100